2012 | 2011 | All

Leonard R, Hennessy BT, Blum JL, O’Shaughnessy J. .
Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer.
Clin Breast Cancer, 11(6):349-356, 2011.     PMID: NA      (Dec 2011)

Liang ZD, Long Y, Tsai WB, Fu S, Kurzrock R, Gagea-Iurascu M, Zhang F, Chen HW, Hennessy BT, Mills G, Savaraj N, Kuo MT. .
Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents.
Mol Cancer Ther 2012, Nov;11(11):2483-94     PMID: 22914438      (Nov 2011)

Gonzalez-Angulo AM (1st), Hennessy BT (1st), Meric-Bernstam F, Sahin A, Liu W, Ju Z, Carey MS, Myhre S, Speers C, Lei D, Broaddus R, Lluch AM, Aparicio S, Brown P, Pusztai L, Symmans WF, Alsner J, Overgaard J, Borresen-Dale AL, Hortobagyi GN, Coombes KR, Mills GB. .
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer.
Clin Proteomics, 8(1):11, 2011     PMID: PMC3170272      (Jul 2011)

Cheung LWT , Hennessy BT, Li J, Yu S, Myers AP, Djordjevic B, Lu Y, Stemke-Hale K, Zheng F, Ju Z, Cantley LC, Scherer SE, Liang H, Lu KH, Broaddus RR, Mills GB. .
High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability.
Cancer Discovery, 1(2):170-185, 2011     PMID: 21984976      (Jul 2011)

Stronach EA, Alfraidi AM, Rama NR, Datler C, Studd JB, Agarwal R, Guney TG, Gourley C, Hennessy BT, Mills GB, Mai A, Brown R, Dina R, Gabra H. .
HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.
Cancer Res, 71(13):4412-4422, 2011.     PMID: 21571862      (Jul 2011)

Tabchy A, Hennessy BT, Gonzalez-Angulo AM, Bernstam FM, Lu Y, Mills GB. .
Quantitative Proteomic Analysis in Breast Cancer.
Drugs Today (Barc), 47(2):169-182, 2011     PMID: NA      (Jul 2011)

Kalachand R, Hennessy BT, Markman M. .
Molecular targeted therapy in ovarian cancer – what is on the horizon?
Drugs, 71(8):947-967, 2011     PMID: 21668036      (May 2011)

Wander SA, Hennessy BT, Slingerland JM. .
Next generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy.
J Clin Invest, 121(4):1231-1241, 2011     PMID: 21490404      (Apr 2011)

Gonzalez-Angulo AM, Timms KM, Liu S, Chen H, Litton JK, Potter J, Lanchbury JS, Stemke-Hale K, Hennessy BT, Arun BK, Hortobagyi GN, Do KA, Mills GB, Meric-Bernstam F. .
Incidence and outcome of BRCA mutations in un triple receptor-negative breast cancer.
Clin Cancer Res, 17(5):1082-1089, 2011     PMID: 21233401      (Mar 2011)

Jotzu C, Alt E, Welte G, Li J, Hennessy BT, Devarajan E, Krishnappa S, Pinilla S, Droll L, Song YH. .
Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors.
Cell Oncol (Dordr), 34(1):55-67, 2011     PMID: 21327615      (Feb 2011)